ARAY
Price
$1.59
Change
+$0.02 (+1.27%)
Updated
Jun 4 closing price
Capitalization
244.95M
70 days until earnings call
IQV
Price
$147.90
Change
+$5.12 (+3.59%)
Updated
Jun 4 closing price
Capitalization
45.3B
54 days until earnings call
Interact to see
Advertisement

ARAY vs IQV

Header iconARAY vs IQV Comparison
Open Charts ARAY vs IQVBanner chart's image
Accuray
Price$1.59
Change+$0.02 (+1.27%)
Volume$801.3K
Capitalization244.95M
IQVIA Holdings
Price$147.90
Change+$5.12 (+3.59%)
Volume$2.68M
Capitalization45.3B
ARAY vs IQV Comparison Chart
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. IQV commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Buy and IQV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (ARAY: $1.59 vs. IQV: $147.90)
Brand notoriety: ARAY: Not notable vs. IQV: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 114% vs. IQV: 108%
Market capitalization -- ARAY: $244.95M vs. IQV: $45.3B
ARAY [@Medical Specialties] is valued at $244.95M. IQV’s [@Medical Specialties] market capitalization is $45.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • IQV’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARAY and IQV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 7 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).

  • ARAY’s TA Score: 7 bullish, 3 bearish.
  • IQV’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than IQV.

Price Growth

ARAY (@Medical Specialties) experienced а 0.00% price change this week, while IQV (@Medical Specialties) price change was +6.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.64%. For the same industry, the average monthly price growth was +3.54%, and the average quarterly price growth was +1.31%.

Reported Earning Dates

ARAY is expected to report earnings on Aug 14, 2025.

IQV is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (+1.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($45.3B) has a higher market cap than ARAY($245M). ARAY YTD gains are higher at: -19.697 vs. IQV (-24.737). IQV has higher annual earnings (EBITDA): 3.26B vs. ARAY (5.93M). IQV has more cash in the bank: 1.5B vs. ARAY (72.8M). ARAY has less debt than IQV: ARAY (202M) vs IQV (13.9B). IQV has higher revenues than ARAY: IQV (15B) vs ARAY (447M).
ARAYIQVARAY / IQV
Capitalization245M45.3B1%
EBITDA5.93M3.26B0%
Gain YTD-19.697-24.73780%
P/E RatioN/A34.14-
Revenue447M15B3%
Total Cash72.8M1.5B5%
Total Debt202M13.9B1%
FUNDAMENTALS RATINGS
ARAY vs IQV: Fundamental Ratings
ARAY
IQV
OUTLOOK RATING
1..100
7310
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
8841
PRICE GROWTH RATING
1..100
5865
P/E GROWTH RATING
1..100
4686
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IQV's Valuation (70) in the Servicestothe Health Industry industry is in the same range as ARAY (86) in the Medical Specialties industry. This means that IQV’s stock grew similarly to ARAY’s over the last 12 months.

IQV's Profit vs Risk Rating (90) in the Servicestothe Health Industry industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to ARAY’s over the last 12 months.

IQV's SMR Rating (41) in the Servicestothe Health Industry industry is somewhat better than the same rating for ARAY (88) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than ARAY’s over the last 12 months.

ARAY's Price Growth Rating (58) in the Medical Specialties industry is in the same range as IQV (65) in the Servicestothe Health Industry industry. This means that ARAY’s stock grew similarly to IQV’s over the last 12 months.

ARAY's P/E Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for IQV (86) in the Servicestothe Health Industry industry. This means that ARAY’s stock grew somewhat faster than IQV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYIQV
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
60%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 4 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGOAX58.66N/A
N/A
Hartford Growth Opportunities A
JIVAX30.07N/A
N/A
JPMorgan U.S. Applied Data Sci Val A
LMORX36.02N/A
N/A
Patient Opportunity R
PRPCX4.94N/A
N/A
PGIM Jennison Energy Infrastructure C
PAHSX6.95N/A
N/A
PGIM Jennison NextGeneration Glb Opps A

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ALGN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+1.27%
ALGN - ARAY
46%
Loosely correlated
+0.46%
IQV - ARAY
44%
Loosely correlated
+3.59%
NVST - ARAY
43%
Loosely correlated
+0.11%
KIDS - ARAY
42%
Loosely correlated
-1.57%
ILMN - ARAY
42%
Loosely correlated
+1.63%
More

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+3.59%
CRL - IQV
73%
Closely correlated
+3.42%
ICLR - IQV
72%
Closely correlated
+4.37%
RVTY - IQV
70%
Closely correlated
+1.51%
TMO - IQV
70%
Closely correlated
+0.93%
A - IQV
69%
Closely correlated
+1.93%
More